Albany, NY -- (SBWire) -- 06/12/2019 --Musculoskeletal Pain Market Insights, Epidemiology and Market Forecast-2028

1. Musculoskeletal Pain total prevalent population was approximately 252,376,708 cases in 2017 in the 7 major markets.
2. Among the EU5 countries, the UK had the highest prevalent population of Musculoskeletal Pain with 21,957,499 cases whereas France had the lowest prevalent population.
3. In terms of gender, most of the diagnosed Musculoskeletal Pain patients are female.

DelveInsight launched a new report on Musculoskeletal Pain Market Insights, Epidemiology and Market Forecast-2028

Key benefits

1. Musculoskeletal Pain market report covers a descriptive overview and comprehensive insight of the Musculoskeletal Pain epidemiology and Musculoskeletal Pain market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Musculoskeletal Pain market report provides insights on the current and emerging therapies.
3. Musculoskeletal Pain market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Musculoskeletal Pain market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Musculoskeletal Pain market.

Request for sample pages

Musculoskeletal Pain therapeutic market in the seven major market was USD 3,764.9 million in 2017. The United States accounts for the largest Musculoskeletal Pain market size and accounts for approximately 60% of the total market in 2017.

Musculoskeletal Pain Treatment is based on the severity of disease and the available Musculoskeletal Pain treatment approaches are symptomatic and supportive in nature. These available Musculoskeletal Pain marketed therapies provide relief for the short term. Hence, medication is required at regular intervals and lack of understanding of Pathophysiology are some of the factors that create urgent demand for more advanced novel therapies for Musculoskeletal Pain treatment.

Musculoskeletal Pain market is expected to grow during the forecast period (2017-2028) due to a number of factors like the rising number of Musculoskeletal Pain patients, increasing awareness, and increasing research and development activities.

The launch of the emerging therapies is expected to significantly impact the Musculoskeletal Pain treatment scenario in the upcoming years:-

Drugs covered
1. NKTR-18
2. Ampion
3. Tanezumab
4. Fasinumab
5. MPC-06-ID
And many others

The key players in Musculoskeletal Pain market are:

1. Nektar Therapeutics
2. Ampio Pharmaceuticals
3. Eli Lilly
4. Pfizer
5. Regeneron Pharmaceuticals
And many others

Table of contents

1. Key Insights
2. Musculoskeletal Pain Market Overview at a Glance
3. Musculoskeletal Pain Disease Background and Overview
4. Musculoskeletal Pain Epidemiology and Patient Population
5. Musculoskeletal Pain Total Prevalent Population in 7MM
6. United States
7. EU5
7.1. Assumptions and Rationale
7.2. Germany
7.3. France
7.4. Italy
7.5. Spain
7.6. United Kingdom
8. Musculoskeletal Pain Treatment in the emergency department
9. Unmet Needs
10. Musculoskeletal Pain Emerging Therapies
10.1. Key Cross Competition
10.2. NKTR-181: Nektar Therapeutics
10.3. Ampion: Ampio Pharmaceuticals
10.4. Tanezumab: Eli Lilly/Pfizer
10.5. Fasinumab: Regeneron Pharmaceuticals
10.6. CNTX-4975 Centrexion Therapeutics
10.7. MPC-06-ID (Rexlemestrocel-L): Mesoblast
10.8. Tizaspray: MDM S.p.A
10.9. CAM2038: Braeburn Pharmaceuticals
10.10. Egalet-002: Egalet Corporation
11. Musculoskeletal Pain Market Analysis 7MM
11.1. Key Findings
11.2. Musculoskeletal Pain Market Size in 7MM
12. United States Market Outlook
13. EU-5 countries Market Outlook
13.1. Germany Market Size
13.2. France Market Size
13.3. Italy Market Size
13.4. Spain Market Size
13.5. United Kingdom Market Size
14. Japan Market Outlook
14.1. Japan Market Size
15. Market Drivers
16. Market Barriers
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight